Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume ...Middle East

Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc....

Read More Details
Finally We wish PressBee provided you with enough information of ( Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume )

Also on site :

• 'General Hospital' Fans Brace for 'Slap in the Face' amid Star's Return
• Scott Miller Passes Away
• Israel-Iran conflict: List of key events, June 21, 2025